According to Race Oncology's latest financial reports the company's current EPS (TTM) is -$0.04084. In 2023 the company made an earnings per share (EPS) of -$0.04084 an increase over its 2022 EPS that were of -$0.05009.
Year | EPS | Change |
---|---|---|
2023 | -$0.04084 | -18.46% |
2022 | -$0.05009 | 37.74% |
2021 | -$0.03637 | 47% |
2020 | -$0.02474 | -23.41% |
2019 | -$0.03230 | -53.58% |
2018 | -$0.06959 | 14.62% |
2017 | -$0.06071 | 190.27% |
2016 | -$0.02092 | |
2015 | N/A |